Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Alkermes Completes Enrolment for Phase II ALKS 3831 Study
Alkermes Completes Enrolment for Phase II ALKS 3831 Study
Alkermes Completes Enrolment for Phase II ALKS 3831 Study
Submitted by
admin
on September 5, 2014 - 7:57am
Source:
Yahoo/Zacks.com
News Tags:
Alkermes
ALKS 3831
schizophrenia
Headline:
Alkermes Completes Enrolment for Phase II ALKS 3831 Study
Do Not Allow Advertisers to Use My Personal information
